QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

ASLAN Pharmaceuticals (ASLN) News Today

$0.71
-0.17 (-19.23%)
(As of 03/1/2024 ET)
SourceHeadline
msn.com logoTech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
msn.com - February 29 at 11:27 AM
globenewswire.com logoASLAN Pharmaceuticals Receives Favorable Opinion From the European Patent Office on Composition of Matter Patent Application for Farudodstat
globenewswire.com - February 29 at 7:00 AM
msn.com logoBank, Auto Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Wednesday
msn.com - February 28 at 12:55 PM
msn.com logoAsian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
msn.com - February 27 at 10:51 AM
finance.yahoo.com logoASLAN Pharmaceuticals Limited (ASLN)
finance.yahoo.com - February 20 at 8:30 PM
morningstar.com logoASLAN Pharmaceuticals Ltd ADR
morningstar.com - February 20 at 3:29 PM
wsj.com logoAslan Pharmaceuticals Ltd. ADR
wsj.com - February 17 at 8:19 AM
msn.com logoTechnology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading
msn.com - December 14 at 12:40 PM
finanznachrichten.de logoASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat Programs
finanznachrichten.de - December 12 at 10:25 AM
finance.yahoo.com logoASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat Programs
finance.yahoo.com - December 12 at 10:25 AM
msn.com logoAsian Equities Traded in the US as American Depositary Receipts Open Week Sharply Lower in Monday Trading
msn.com - December 4 at 12:43 PM
finance.yahoo.com logoASLAN Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference
finance.yahoo.com - November 20 at 9:59 AM
morningstar.com logoASLAN Pharmaceuticals Ltd ADR ASLN
morningstar.com - November 4 at 9:53 AM
finance.yahoo.com logoASLAN Pharmaceuticals Presents New Data on Eblasakimab in Atopic Dermatitis and COPD Translational Models at the 7th Dermatology Drug Development Summit
finance.yahoo.com - November 3 at 7:17 AM
markets.businessinsider.com logoPiper Sandler Reaffirms Their Buy Rating on Aslan Pharmaceuticals (ASLN)
markets.businessinsider.com - October 31 at 11:46 PM
markets.businessinsider.com logoAslan Pharmaceuticals: Promising Financial Results and Optimistic Drug Trial Outcomes Boost Buy Rating
markets.businessinsider.com - October 31 at 11:46 PM
finance.yahoo.com logoASLAN Pharmaceuticals to Co-Host KOL Panel Discussion Today on Changes in the Clinical Trial and Treatment Landscape for Atopic Dermatitis
finance.yahoo.com - October 24 at 12:09 PM
finance.yahoo.com logoASLAN Pharmaceuticals to Co-Host KOL Panel Discussion on Changes in the Clinical Trial and Treatment Landscape for Atopic Dermatitis
finance.yahoo.com - October 18 at 7:51 AM
fool.com logoASLAN Pharmaceuticals (NASDAQ: ASLN)
fool.com - October 15 at 2:31 PM
finance.yahoo.com logoASLAN Pharmaceuticals Presents New Data From Phase 2b Study of Eblasakimab in Atopic Dermatitis in Late Breaker Presentation at 32nd European Academy of Dermatology and Venereology Congress
finance.yahoo.com - October 13 at 2:19 PM
msn.com logoTech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading
msn.com - October 2 at 12:47 PM
finance.yahoo.com logoASLAN Pharmaceuticals Announces Acceptance of Late Breaker Abstract on Eblasakimab Phase 2b Results as Oral Presentation and Three Additional Abstracts at 32nd European Academy of Dermatology and Venereology Congress
finance.yahoo.com - September 22 at 7:13 AM
finance.yahoo.com logoASLAN Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - September 7 at 11:19 AM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Aslan Pharmaceuticals (ASLN)
markets.businessinsider.com - August 14 at 10:33 PM
msn.com logoIndexes Mixed After Economic Data; Walmart Rises On Analyst Upgrade As Earnings Loom
msn.com - August 11 at 4:32 PM
finance.yahoo.com logoASLAN Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 11 at 4:32 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Their Buy Rating for Aslan Pharmaceuticals (ASLN)
markets.businessinsider.com - July 7 at 3:19 PM
msn.com logoAslan Pharmaceuticals shares slide amid new data on atopic dermatitis treatment
msn.com - July 6 at 1:09 PM
finance.yahoo.com logoWhat's Going On With ASLAN Pharmaceuticals Stock Today?
finance.yahoo.com - July 6 at 1:09 PM
finance.yahoo.com logoEblasakimab Monthly Dosing Shows Potential for Best-In-Class Therapy in Positive Phase 2b Study in Atopic Dermatitis
finance.yahoo.com - July 6 at 8:09 AM
finance.yahoo.com logoASLAN Pharmaceuticals to Host Webcast on July 6, 2023, to Discuss Phase 2b Topline Data From TREK-AD Trial Evaluating Eblasakimab in Atopic Dermatitis
finance.yahoo.com - July 5 at 8:01 PM
msn.com logoHC Wainwright & Co. Reiterates ASLAN Pharmaceuticals Ltd - ADR (ASLN) Buy Recommendation
msn.com - June 26 at 10:23 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN) and Roivant Sciences (ROIV)
markets.businessinsider.com - June 23 at 7:43 AM
finance.yahoo.com logoASLAN Pharmaceuticals Announces Publication in Clinical Immunology Highlighting Eblasakimab’s Unique Mechanism of Action in the Treatment of Atopic Dermatitis
finance.yahoo.com - June 23 at 7:43 AM
benzinga.com logoASLAN Inks Licensing Deal With Zenyaku Kogyo To Commercialize Eblasakimab In Japan
benzinga.com - June 22 at 3:10 PM
finance.yahoo.com logoASLAN Pharmaceuticals Enters Into a Strategic Licensing Deal With Zenyaku Kogyo for the Development and Commercialization of Eblasakimab in Japan
finance.yahoo.com - June 22 at 10:09 AM
markets.businessinsider.com logoPiper Sandler Remains a Buy on Aslan Pharmaceuticals (ASLN)
markets.businessinsider.com - June 14 at 1:42 PM
msn.com logoAsian Equities Rebound in Thursday Trading
msn.com - June 4 at 12:09 AM
finance.yahoo.com logoASLAN Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
finance.yahoo.com - June 1 at 10:38 AM
msn.com logoRoth MKM Initiates Coverage of ASLAN Pharmaceuticals Ltd - ADR (ASLN) with Buy Recommendation
msn.com - May 31 at 2:23 PM
finance.yahoo.com logoASLAN Pharmaceuticals Doses First Patient in Phase 2a Trial of Farudodstat in Alopecia Areata
finance.yahoo.com - May 18 at 7:57 AM
finance.yahoo.com logoASLAN Pharmaceuticals Presents New Data on Eblasakimab and Farudodstat in Two Late-Breaking Presentations at the 1st International Societies for Investigative Dermatology Meeting
finance.yahoo.com - May 15 at 8:35 AM
msn.com logoHC Wainwright & Co. Maintains ASLAN Pharmaceuticals Ltd - ADR (ASLN) Buy Recommendation
msn.com - April 29 at 10:07 AM
finanznachrichten.de logoASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - April 28 at 9:14 AM
finance.yahoo.com logoASLAN Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - April 28 at 9:14 AM
finance.yahoo.com logoASLAN Pharmaceuticals Announces Four Abstracts on Eblasakimab and Farudodstat, Including Two Late-Breakers, to be Presented at the 1st International Societies for Investigative Dermatology Meeting
finance.yahoo.com - April 24 at 10:11 AM
msn.com logoAre Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
msn.com - April 5 at 3:12 PM
msn.com logoASLAN Pharmaceuticals regains compliance with minimum bid price
msn.com - March 28 at 3:42 PM
finanznachrichten.de logoASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
finanznachrichten.de - March 28 at 8:16 AM
finance.yahoo.com logoASLAN Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
finance.yahoo.com - March 28 at 8:16 AM
Get ASLAN Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter.



ASLN Media Mentions By Week

ASLN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ASLN
News Sentiment

0.38

0.62

Average
Medical
News Sentiment

ASLN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ASLN Articles
This Week

6

1

ASLN Articles
Average Week

Get ASLAN Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ASLN) was last updated on 3/1/2024 by MarketBeat.com Staff